Korro Bio (KRRO) Total Current Liabilities (2018 - 2026)

Korro Bio's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $14.8 million for Q1 2026.

• Quarterly Total Current Liabilities rose 14.8% year-over-year to $14.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.8 million (up 14.8% YoY) and the FY2025 annual result came in at $11.9 million, down 20.21% from the prior year.
• Total Current Liabilities was $14.8 million for Q1 2026 at Korro Bio, up from $11.9 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $22.0 million in Q1 2023 and bottomed at $8.3 million in Q2 2023.
• A 5-year average of $14.1 million and a median of $13.6 million in 2024 frame the typical range for Total Current Liabilities.
• Peak annual rise in Total Current Liabilities reached 123.92% in 2023, while the deepest fall reached 51.95% in 2023.
• Korro Bio's Total Current Liabilities stood at $8.7 million in 2022, then jumped by 123.92% to $19.5 million in 2023, then decreased by 23.22% to $15.0 million in 2024, then retreated by 20.21% to $11.9 million in 2025, then grew by 23.88% to $14.8 million in 2026.
• Business Quant data shows KRRO's Total Current Liabilities at $14.8 million in Q1 2026, $11.9 million in Q4 2025, and $14.6 million in Q3 2025.